EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

  1. Dixon, W.G.
  2. Carmona, L.
  3. Finckh, A.
  4. Hetland, M.L.
  5. Kvien, T.K.
  6. Landewe, R.
  7. Listing, J.
  8. Nicola, P.J.
  9. Tarp, U.
  10. Zink, A.
  11. Askling, J.
Journal:
Annals of the Rheumatic Diseases

ISSN: 1468-2060 0003-4967

Year of publication: 2010

Volume: 69

Issue: 9

Pages: 1596-1602

Type: Article

DOI: 10.1136/ARD.2009.125526 GOOGLE SCHOLAR